Clinical trials are getting more difficult as sponsors target more complex diseases and treatments, and regulators demand more proof before approving new products. To generate the amount of evidence needed for regulators and payors, clinical trials need to be larger and longer than ever before – increasing costs and putting an additional burden on participants.
By linking clinical trials to participants’ real-world data, sponsors can tap into ubiquitous data sources collected as part of routine care to fill gaps in key evidence. To break down data silos and connect trials to the largest US-based RWD ecosystems, Medidata Link seamlessly integrates into existing workflows to manage the process for obtaining consent and personally-identifying information – all while minimizing site burden and costs.
Discover how clinical trial data (CTD) and RWD can be linked through Medidata Link at the participant level, enhancing the generation of evidence beyond what is possible in conventional clinical trials.